Current Antimalarial Therapies and Advances in the Development of Semi-Synthetic Artemisinin Derivatives

AUTOR(ES)

PINHEIRO, LUIZ C.S., FEITOSA, LÍVIA M., SILVEIRA, FLÁVIA F. DA, BOECHAT, NUBIA

FONTE

An. Acad. Bras. Ciênc.

DATA DE PUBLICAÇÃO

2018

RESUMO

ABSTRACT According to the World Health Organization, malaria remains one of the biggest public health problems in the world. The development of resistance is a current concern, mainly because the number of safe drugs for this disease is limited. Artemisinin-based combination therapy is recommended by the World Health Organization to prevent or delay the onset of resistance. Thus, the need to obtain new drugs makes artemisinin the most widely used scaffold to obtain synthetic compounds. This review describes the drugs based on artemisinin and its derivatives, including hybrid derivatives and dimers, trimers and tetramers that contain an endoperoxide bridge. This class of compounds is of extreme importance for the discovery of new drugs to treat malaria.

Documentos Relacionados

• Bergenin of Peltophorum dubium (Fabaceae) Roots and Its Bioactive Semi-Synthetic Derivatives
• Antimicrobial activity of the myrsinoic acid A from Myrsine coriacea and the semi-synthetic derivatives
• Developing Commercial Production of Semi-Synthetic Artemisinin, and of β-Farnesene, an Isoprenoid Produced by Fermentation of Brazilian Sugar
• Design and calibration of a semi-synthetic DNA phasing assay
• Evaluation of antimicrobial activity of extracts of Tibouchina candolleana (melastomataceae), isolated compounds and semi-synthetic derivatives against endodontic bacteria